title: Rapid conversion from aluminium bone disease to hyperparathyroid bone disease by desferrioxamine.
authors.forename: N
authors.initials: N
authors.lastname: Terao
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: S
authors.initials: S
authors.lastname: Homma
authors.forename: Y
authors.initials: Y
authors.lastname: Asano
authors.forename: S
authors.initials: S
authors.lastname: Hosoda
authors.forename: M
authors.initials: M
authors.lastname: Furuse
mesh_terms: D000328:Adult; D000535:Aluminum / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced*; D003676:Deferoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005598:Fractures, Spontaneous / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D006961:Hyperparathyroidism / Q000139:chemically induced*; D006965:Hyperplasia; D010018:Osteomalacia / Q000209:etiology; D010280:Parathyroid Glands / Q000473:pathology; D011630:Pubic Bone / Q000293:injuries*; D006435:Renal Dialysis / Q000009:adverse effects; D012253:Rib Fractures / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000535:Aluminum; D003676:Deferoxamine